This medication has proven to be a game-changer, demonstrating a substantial reduction in the five-year risk of recurrent cancer by an impressive 73% ... Nov 14
Aditi Shankar's historic journey from dialysis to a drug-free transplant represents a remarkable triumph of medical science, innovation, and human resilience. Her story ... Sep 23
One in 5 women have PCOS. It is not a disease but a metabolic endocrine disorder. Lifestyle modification can treat this disorder very well. Know ... Mar 01
Read on to know some healthy options that are good for your kidney ... Oct 22
Latest Pharma News Update... Aug 23
Fusion Pharmaceuticals Announces FDA Clearance of IND for FPI-1966 ... Jul 30
Finerenone has also been submitted for marketing authorization in the European Union (EU) and in China... Jul 12
... May 18
Tecentriq is now the first and only single-agent cancer immunotherapy with three dosing options... May 08
Chronic Kidney Disease needs attention and early intervention to protect the kidney from dialysis. The FDA has approved Farxiga to AstraZeneca to help protect kidney ... May 07
Reproductive Planning and Safe Motherhood is learning about one’s own body and its changes, getting the right information, and seeking the right advice from ... Apr 24
Dr. Shilpa Jasubhai, Clinical Psychologist, highlights main traits of dissociative Identity disorder, healing strategies from DID, how to help a friend suffering from this disorder ... Apr 07
... Mar 31
Takeover to advance T-Cell Activator Solid Tumor Treatments and expand new Cancer Immunotherapy Portfolio... Mar 13
Hoth Therapeutics, Inc. a biopharmaceutical company, today announced that it has signed a production agreement for both GLP and GMP materials associated with HT-001 ... Jan 01
Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk of disease recurrence or death by 80%... Dec 21
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose ... Dec 19
Blueprint Medicines requested priority review for this application, which, if granted, could result in a six-month review process... Dec 18
European Commission decision marks the first time a dual immunotherapy with limited chemotherapy is approved for patients with non-small cell lung cancer in the ... Nov 09
To continue with the trend BMC decided to provide free COVID-19 test at 244 places... Nov 03
Roche receives FDA approval for the cobas EGFR mutation test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with ... Oct 30
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
NKMax America has developed a proprietary NK cell expansion and activation technology platform which allows it to produce unprecedented commercial amounts of autologous and allogeneic ... Oct 20
Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ... Oct 03
-Advertisements-
Saturday, June 01, 2024
.jpg)
